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Abstract
Mycobacterium abscessus is an emerging human pathogen responsible for lung infections, skin and soft-tissue infections and
disseminated infections in immunocompromised patients. It may exist either as a smooth (S) or rough (R) morphotype, the
latter being associated with increased pathogenicity in various models. Genetic tools for homologous recombination and
conditional gene expression are desperately needed to allow the study of M. abscessus virulence. However, descriptions of
knock-out (KO) mutants in M. abscessus are rare, with only one KO mutant from an S strain described so far. Moreover, of the
three major tools developed for homologous recombination in mycobacteria, only the one based on expression of phage
recombinases is working. Several conditional gene expression tools have recently been engineered for Mycobacterium
tuberculosis and Mycobacterium smegmatis, but none have been tested yet in M. abscessus. Based on previous experience with
genetic tools allowing homologous recombination and their failure in M. abscessus, we evaluated the potential interest of
a conditional gene expression approach using a system derived from the two repressors system, TetR/PipOFF. After several
stepsnecessarytoadaptTetR/PipOFFforM.abscessus,wehaveshowntheefficiencyofthissystemforconditionalexpressionof
an essential mycobacterial gene, fadD32.I n h i b i t i o no ffadD32 was demonstrated for both the S and R isotypes, with marginally
betterefficiencyfortheRisotype.ConditionalgeneexpressionusingthededicatedTetR/PipOFFsystemvectorsdevelopedhere
is effective in S and R M. abscessus, and may constitute an interesting approach for future genetic studies in this pathogen.
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Introduction
Mycobacterium abscessus is an emerging, rapidly growing mycobac-
terium (RGM) that causes a wide spectrum of disease in humans,
includingchroniclungdisease,skinandsofttissuedisease,meningitis,
meningoencephalitis, and disseminated disease in patients receiving
immunosuppressivetherapy[1,2,3].M.abscessuslungdisease ishighly
prevalent in patientswith cystic fibrosis (CF)and isbecoming a major
issue for most CF centres worldwide [4,5,6]. M. abscessus is also
a leading cause of sporadic and epidemic cases of skin and soft-tissue
infections after surgery or following the use of contaminated syringes
and needles [7,8], with reports of several large outbreaks associated
with injection of adrenal cortex extract, abdominoplasty, laparo-
scopic surgeries, mesotherapy, tattooing and piercing [9]. M. abscessus
is one of the most antibiotic-resistant RGM species: it is naturally
resistant to conventional anti-tuberculous drugs and only very few
drugs are potentially active [1,10].
Although a rapid grower, M. abscessus has the ability to induce
a chronic disease associated with granuloma formation and on
occasion caseous lesions [11,12,13]. Moreover, this species may
exist in the form of a smooth (S) or rough (R) isotype, the latter
being associated with more severe disease [4,12], and with
increased pathogenicity in various in vitro and in vivo models
[13,14,15,16]. With the recent availability of its complete genome
sequence [17], M. abscessus is now a particularly relevant model for
studying pathogenic mechanisms of mycobacterial disease [10].
However, research molecular microbiology and pathophysiology
of diseases caused by M. abscessus has been hampered by the lack of
genetic tools working on this agent, and the absence of knock-out
mutants, with only one described so far from an S isotype [18].
Several genetic tools for mutagenesis by homologous recombina-
tion and conditional gene expression have been extensively
modified and engineered for use in mycobacteria. Two thermo-
sensitive systems [19,20] and a plasmid encoding phage-recombi-
nases [21] were used for homologous recombination. Several
regulated expression systems were developed to control gene
expression in mycobacteria. The first described expression system
was based on the acetamide-inducible promoter of M. smegmatis
[22]. Other systems used for modulating gene expression in M.
tuberculosis were based on the TetR repressor [23,24,25] and
revTetR [26,27]. Alternate systems included the Streptomyces
coelicolor pristinamycin I repressor Pip [28], the Rhodococcus
rhodochrous nitrilase repressor NitR [29] and the recently described
TetR/PipOFF double repressor system [30].
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Mycobacterium bovis strain BCG or M. smegmatis are generally
considered to be able to work in virtually all mycobacteria.
However, this was recently found not to be the case for M. abscessus
for the tools devoted to mutagenesis by homologous recombina-
tion. Indeed poor results were obtained with the thermosensitive
counterselectable plasmid based on sucrose sensitivity [19] and the
thermosensitive mycobacteriophage [20]. Only the most recently
developed mycobacterial recombinase-based system [21] was used
successfully in M. abscessus [18]. Despite this, the percentage of
recombinants by homologous recombination with a double
crossing-over was very low as compared to M. smegmatis, which
still renders this tool cumbersome for the development of M.
abscessus knock-outs [18].
Therefore research into M. abscessus, an emerging virulent
pathogen, is still hampered by the lack of effective genetic tools.
For this reason, we have considered the key role of regulated
expression systems for studying mycobacteria pathogenesis, as we
felt it was of outmost importance to test and adapt one of the last
described repressor system in this mycobacterium. Previous
experiments performed on tools for homologous recombination
in our laboratory required us to modify the existing TetR/PipOFF
system and to clone the different promoters in integrative vectors
known to work in M. abscessus. We then studied the efficiency of
the adapted TetR/PipOFF system firstly by controlling lacZ
expression in M. abscessus, and secondly by characterizing its role
as an essential gene of fadD32 in M. abscessus. Our results have
shown the difficulties encountered in adapting existing mycobac-
terial tools for M. abscessus, and we describe for the first time its
success in this mycobacterium and confirmed the efficacy of the
plasmid encoding phage – recombinases in creating recombinant
by single cross-over in M. abscessus.
Results
Construction of TetR/PipOFF system vectors for M.
abscessus
The TetR/PipOFF repressible system was cloned into the
vector pMV306, which is an integrative vector coding for the
kanamycin resistance, and which has demonstrated of its efficiency
in M. abscessus. Two integrative constructs were prepared and
inserted in the M. abscessus genome: pMC30A (lacZ(R);tetR(r);
pip(r)) and pMC30B (lacZ(R);tetR(R);pip(r)) (Table 1 and
Figure 1). To control the potential effect the integrative plasmid
had by itself we also inserted the integrative vector pMVlac
(pMV306 with Pptr-lacZ) described above (Table 1 and Figure 1).
Functionality of the TetR/PipOFF constructs in M.
smegmatis
pMC30A, pMC30B, pMVlac plasmids, and the pFRA42A
(kindly provided by Boldrin et al.) [30] were electroporated into M.
smegmatis mc
2155 strain, to demonstrate their respective function-
ality (Figure S1). As a negative control, M. smegmatis mc
2155 strain
was shown to have no b-galactosidase activity (Figure 2). By
comparison, b-galactosidase activity was obtained in each
transformant, with activity ranging from 123, 67 and 71 Miller
units without ATc respectively for mc
2155-pFRA42A and
mc
2155-pMC30A or -pMC30B respectively (Figure 2). By
comparison, b-galactosidase activity was high in mc
2155-pMVlac,
with 8396228 Miller units in absence of ATc (Figure 2). Similarly,
b-galactosidase activity decreased by 12 and 10-fold respectively in
mc
2155-pMC30A and mc
2155-pMC30B after 24 h and 42 h of
incubation in presence of ATc (Figure 2). By comparison, the
presence of ATc had no impact on the b-galactosidase activity of
mc
2155-pMVlac, with 781695 Miller units and 864689 Miller
units after 24 h and 42 h of incubation (Figure 2).
Functionality of the TetR/PipOFF constructs in M.
abscessus S isotype
Once the functionality of pMC30A and pMC30B were
confirmed in M. smegmatis as compared to pFRA42A, pMC30A
and pMC30B plasmids were then electroporated in M. abscessus
strain CIP 104536T (S isotype), in addition to pMVlac as a positive
control. b-galactosidase activity was expressed as the ratio of the
activity observed in presence of ATc (100, 200 and 300 ng/ml) to
the activity obtained in the absence of ATc. Such ATc
concentrations were well below tetracycline MIC described towards
M. abscessus (range 8 to 128 mg/ml) [31]. This activity was measured
and expressed as a percentage at 24, 48 and 72 h. M. abscessus S
strain had no b-galactosidase activity. b-galactosidase activity in M.
abscessus- pMC30A S isotype was decreased by 52% at 24 h,62%at
48 h and nearly 67% at 72 h in the presence of 100 ng/ml of ATc
as compared to the b-galactosidase activity measured in absence of
ATc. Increasing ATc concentrations had only a slight negative
effect on the b-galactosidase activity in M. abscessus S isotype. b-
galactosidase activity in M. abscessus - pMC30A S isotype was
decreased by 60% fold at 24 h, 72% fold at 48 h and at 72 h at
a concentration of 200 ng/ml of ATc as compared to the b-
galactosidase activity in the absence of ATc. Similar results were
obtained at 300 ng/ml of ATc compared to 200 ng/ml. M. abscessus
- pMVlac S isotype demonstrate of a b-galactosidase activity 8 times
higher compared to M. abscessus - pMC30A S isotype in the absence
of ATc (data not shown), and kept this activity throughout the
experiment (data not shown). Similar results were obtained with
both integrative plasmids pMC30A and pMC30B (Figure 3A).
Functionality of the TetR/PipOFF constructs in M.
abscessus R isotype
The same series of experiments were performed using a well-
documented R isotype from M. abscessus CIP 104536T [15]. b-
galactosidase activity in the presence of 100 ng/ml of ATc in M.
abscessus - pMC30A R isotype was decreased by 54% at 24 h, and
76% at 48 h and at 72 h which closely corresponded to b-
galactosidase values obtained for the isotype S in the presence of
200 ng/ml of ATc (Figure 3B). In fact, the inhibition of the b-
galactosidase activity in M. abscessus R isotype was slightly more
efficient at low ATc concentrations as compared to the S isotype
(Figure 3B). Increasing the ATc concentrations also increased the
inhibition of b-galactosidase activity as shown by decreased values
observed in the presence of 200 ng/ml or 300 ng/ml of ATc
(Figure 3B). b-galactosidase activity in M. abscessus - pMC30A R
isotype was decreased by nearly 64% at 24 h and 82% at 48 h and
at 72 h respectively as compared to the b-galactosidase activity in
the absence of ATc. Similar results were obtained with both
integrative plasmids pMC30A and pMC30B (Figures 3A and 3B).
Future described experiments will be performed using plasmid
pMC30A and an ATc concentration of 200 ng/ml, where we
have obtained satisfactory gene repression.
Construction of fadD32 conditional mutants (fad32
c)i n
M. abscessus S and R isotypes
The results presented above demonstrated that the regulated
TetR/PipOFF system works in M. abscessus S and R isotypes, with
a marginally better efficiency in the R isotype. These results
prompted us to test the ability of the TetR/PipOFF system to
unravel essential genes by creating conditional mutants. fadD32,
a gene involved in fatty acid biosynthesis, was chosen as a test-
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[28,32]. The fadD32 gene of M. tuberculosis (Rv3801c) has orthologs
in M. smegmatis (MSMEG_6393, Blastp: 76% identities and 87 %
positives) and M. abscessus (MAB_0179, BlastP: 66% identities and
81 % positives). Genomic organization in the fad32 region was
similar in all three mycobacterial species.
To create the conditional fadD32 mutant in M. abscessus,w ec l o n e d
the 59region of fadD32 under the control of Pptr giving plasmid pMC18
(Figure 4A). After electroporation and zeocin selection, we checked for
recombinants with a single cross-over in all the clones growing in the
presence of zeocin. Such single cross-over allows replacement of the
wild-type gene under the control of its own promoter by the 59
truncated part of fadD32 under the control of Pptr (Figure 4A).
Conditional mutants were searched for by PCR using primers MC77
and fadV (Table 2) giving the expected fragment of 1700 bp. This
PCR was negative in the wild type strain and on plasmid pMC18 (see
Figure 4B lanes 1–4). Replacements were performed in both S and R
isotypes giving strains S fadD32
C and R fadD32
C.
fadD32
C growth characteristics in presence of ATc
After transformation of plasmid pMC30A or pMVlac in fadD32
C
S and R strains, growth analysis was performed in the presence or
absence of 200 ng/ml of ATc by spotting 5 ml of the liquid cultures
of each conditional mutant and wild type strain (Figure 5A). The
growth of wild type M. abscessus strain (S and R isotype) was similar
with or without ATc (Figure 5A, lane 1 and 5).
For S fadD32
C and R fadD32
C strains containing the plasmid
pMVlac or not, their growth was unchanged in the presence of
Table 1. Strains and plasmids used in this study.
Strains or plasmid Relevant characteristics or sequence Reference or source
E. coli DH5a Invitrogen (Paisley, UK)
M. smegmatis mc
2155 [38]
M. abscessus S CIP 104536T (= ATCC19977T), Smooth [15]
M. abscessus R CIP 104536T (= ATCC19977T), Rough [15]
M. abscessus S fadD32
C SP ptr-fadD32 This study
M. abscessus R fadD32
C RP ptr-fadD32 This study
pJV53 chec9 genes gp60_61 under the control of the acetamidase promoter [21]
pBSKIISK (+) Cloning vector; Amp
R Stratagene
pLYG204.Zeo Plasmid encoding a Zeo
R cassette [45]
pMV306 Kn
R,i n t ,attP integrates at attB site on mycobacterial chromosome [46]
pMVlac pMV306 containing lacZ under Pptr promoter This study
pMC30A pMVlac containing PfurA102tetO-pip and Psmyc-tetR in the same sense This study
pMC30B pMVlac containing PfurA102tetO-pip and Psmyc-tetR in the opposite sense This study
pFRA42A Psmyc-tetR; PfurA102tetO-pip; Pptr-lacZ; int;S m
R [30]
pFRA61 Psmyc-tetR; PfurA102tetO-pip (Sm) From R. Manganelli
pFRA50 pSM240 derivative; Pptr; (Hyg) [30]
pMC14 pFRA50 with Zeo
R cassette This study
pMC18 pMC14 with Pptr-first 953 bp of M. abscessus fadD32 This study
Amp
R, ampicillin resistance; Hyg
R, Hygromycin resistance; Kn
R, kanamycin resistance; Zeo
R, zeocin resistance; Sm
R, Streptomycin resistance.
doi:10.1371/journal.pone.0029306.t001
Figure 1. Schematic representation of plasmids pMVlac, pMC30A and pMC30B. Plasmids are derivative of the empty vector pMV306. In
pMVlac, the Pptr promoter and lacZ was cloned in pMV306. In pMC30A or pMC30B, Psmyc-tetR and PfurA102tetO-pip were cloned in pMVlac in the same
or opposite direction. int: gene coding for an integrase; kn
R: kanamycin resistance gene; oriE: replication origin in E.coli; attP: site-specific
recombination; lacZ: gene coding for b-galactosidase; pip: gene coding for the protein Pip, a repressor of the Pptr promoter; tetR: gene coding for
TetR, a repressor of the PfurA102tetO promoter in absence of ATc; Psmyc: constitutive promoter; PfurA102tetO: promoter repress by TetR; Pptr: promoter
repress by the protein Pip.
doi:10.1371/journal.pone.0029306.g001
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the Pptr promoter (Figure 5A, lane 2, 3, 6 and 7).
Strains S fadD32
C-pMC30A and R fadD32
C-pMC30A growth
were similar as the wild type strain growth in absence of ATc.
Reduction of growth was observed in presence of 200 ng/ml ATc
for the S fadD32
C-pMC30A as shown by the absence of colonies
after spotting 5 ml at dilutions 10
22 and 10
23 respectively
(Figure 5A, lane 4). The absence of growth was observed for the
R fadD32
C-pMC30A, as shown by the non-existence of any
colonies from pure and 10
21 dilution (figure 5A, lane 8). Such
results confirmed the inhibitory role of Pip towards Pptr promoter
in presence of ATc. These experiments demonstrate the inability
of M. abscessus fad32
C to grow in the presence of ATc,
demonstrating its essential role in M. abscessus.
Growth with or without ATc was also controlled in liquid
culture. Diluted liquid culture aliquots of S fadD32
C-pMC30A and
R fadD32
C-pMC30A were separated into two cultures: one
without ATc and one with 200 ng/ml ATc. After 48 h, OD600nm
was measured and CFU counts were numbered on LB agar plates
(Figure 5B). CFU counts showed that S fadD32
C-pMC30A and R
fadD32
C-pMC30A growths were decreased, in the presence of
ATc, by 93 and 99% of the values of the initial inocula respectively
(Figure 5B). Optical density values at 600 nm were similar, with or
without ATc, for both S/R fadD32
C-pMC30A variants (data not
shown). These results were in agreement with data obtained on
solid medium.
To confirm these results, the expression level of fadD32 was
measured by quantitative RT-PCR (qRT-PCR) in both fadD32
C
strains after 48 h with or without 200 ng/ml ATc. As shown in
figure 6A, when fadD32 was positioned under the Pptr promoter
(strain S fadD32
C), its expression was 5-fold higher than with its
own promoter. When the TetR/PipOFF system was introduced
(via pMC30A) into this construct, the expression of fadD32 was
decreased but was still higher than in the wild type strain. In the
presence of 200 ng/ml of ATc, qRT-PCR confirmed the total
absence of fadD32 mRNA and by so the inhibitory activity linked
to the TetR/PipOFF system. Similar results were obtained in the
R strain (Figure 6B).
In conclusion, these experiments have demonstrated for the first
time the functionality of the TetR/PipOFF regulated system in M.
abscessus on lacZ and fadD32 genes. We have confirmed that fadD32
is also an essential gene in M. abscessus.
Discussion
Ever since the recognition recently in 1992 of M. abscessus as
a species, the number of clinical reports of infections due to M.
abscessus has increased annually, mainly but not exclusively
affecting subjects with predisposing conditions (e.g., Cystic
Fibrosis, or those receiving immunosuppressive therapy). Aside
from its role as an emerging pathogen, M. abscessus may function
as a suitable surrogate host for the study of mycobacterial
infections in general. Like M. smegmatis, it grows rapidly on
conventional culture media and is a level 2 pathogen. However, it
shares a number of traits with slow-growing mycobacterial
pathogens, such as the formation of caseous lesions [13] and the
ability to persist silently for decades in the human host [10].
Several relevant in vivo and ex vivo models of infections have
already been developed [13,14,15,33] and its complete genome
sequence is now available [17].
However, a true understanding of the genetics of M. abscessus is
still in its infancy with only one KO mutant described so far [18].
M. abscessus is indeed one of the most resistant of the mycobacteria,
Figure 2. Assays with vectors pMC30A and pMC30B containing TetR/Pip OFF system in M. smegmatis. mc
2155 and mc
2155- pMVlac, -
pFRA42A, -pMC30A and pMC30B were cultured in Luria-Bertani broth, and their respective b-Galactosidase activity was measured at 0 h, 24 h and
42 h in presence of 50 ng/ml ATc. Results were expressed in Miller units. mc
2155 with or without pFRA42A serve as negative and positive control
respectively.
doi:10.1371/journal.pone.0029306.g002
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when selecting for recombinants, which has hampered the use of
common resistance markers. In addition, its metabolism and the
optimal temperature for growth may differ between M. abscessus
and other mycobacterial species. For example, the absence of
a sucrose import system in M. abscessus would explain the lack of
toxicity in the presence of sucrose; even if the sacB gene is
expressed. This makes the thermosensitive counterselectable
plasmid based on sucrose sensitivity inefficient [19]. In addition,
M. abscessus does not grow above 39uC (the temperature for its
optimal growth being 28uC), rendering the 40uC counterselection
impossible. Finally, its S to R switch may modify the permeability
of the outer layer, and the presence of a DNA degradation locus
[34], a full plasmid and a complete phage [17] might restrict the
efficiency of foreign DNA integration and/or recombination into
the chromosome, either by DNA degradation or incompatibility.
Having taken into account all of these mycobacterial properties,
we decided to test the recently developed TetR/PipOFF system,
which has previously proven to be extremely useful in the
detection and study of conditional mutants in M. tuberculosis and M.
smegmatis [30,35]. The TetR/PipOFF system allows repression to
be achieved by the addition of ATc rather than its removal from
the culture medium. The ATc based induction of the Pip-encoding
gene permits a tight repression of the gene under investigation
[30]. Several steps were necessary to adapt the TetR/PipOFF
system to M. abscessus. Firstly, it was necessary to use different and
integrative vectors coding for the zeocin resistance. This resistance
marker was shown to be more efficient than the kanamycin
resistance marker, by selecting far fewer spontaneous antibiotic-
resistant mutants [18], and was used at a concentration of less than
50 mg/ml. The second step was to achieve a recombination event,
by single cross-over. We firstly electroporated the recently
developed mycobacterial recombinase-based system pJV53 [21]
in M. abscessus S and R isotypes. Plasmid pMC18 was then
electroporated in both S and R isotypes – pJV53 and integration
by single cross-over was checked by amplification. The success of
this gene replacement, which represents only the second published
description so far in M. abscessus, has allowed us to demonstrate,
once again, the efficacy of pJV53 and its recombinases in both
isotypes. Finally, lacZ as a simple marker of expression, and fadD32
as an example of an essential gene have confirmed the
functionality of the adapted TetR/PipOFF in M. abscessus.
However if gene expression can be dramatically reduced in M.
smegmatis and M. tuberculosis with 50 ng/ml and 200 ng/ml of ATc
respectively ([30] and our study), we were unable to obtain
a similar reduction in M. abscessus, even at the highest
concentration of ATc (200 ng/ml). Previous studies have shown
that the MIC for tetracycline is low in M. smegmatis, but higher in
M. tuberculosis, thus explaining the use of a higher ATc
concentration to induce the TetR repression in M. tuberculosis
[25]. Less is known about resistance of M. abscessus towards
tetracycline. Several studies have previously shown that M.
abscessus possesses a number of resistance determinants, which
makes this bacterium more resistant than M. smegmatis or M.
tuberculosis towards ATc [36]. We have also identified a difference
between S and R strains, the R isotype showing a higher level of
lacZ repression for similar ATc concentrations, compared to S
strain. A number of recent studies have shown that the S/R switch
in M. abscessus was associated with the loss of a surface molecule
named glycopeptidolipid (GPL) [13,15,33,37]. The difference
between the S and R strains of M. abscessus might thus be due to
changes of surface properties and the degree of permeability from
the loss of GPL. However, nothing is known regarding
comparative MICs towards ATc for both isotypes. In addition,
the induction of efflux systems was demonstrated to be responsible
for the lower efficiency of ATc used at high concentrations [25].
Several leads might enable us to improve the adapted TetR/
PipOFF system, for example by isolating highly efficient M.
abscessus strains for electroporation, as described several years ago
for M. smegmatis with the isolation of the mc
2155 strain [38]. R
strains form aggregates and tend to stick to plastic surfaces, which
hampered electroporation efficiency. The other improvement
Figure 4. Construction of conditional mutants. (A) Schematic representation of the recombination event used to get the conditional mutant
fadD32
C after a single crossover. The size of PCR product using primers MC77 and fadV is 1700 bp. (B) PCR analysis of construction obtaining for
conditional mutant. Lane 1, 2, 3 and 4: PCR with primer MC77 and fadV. Lane 1: CIP-S fadD32
C; lane 2: CIP-R fadD32
C; lane 3: CIP-S; lane 4: pMC18; lane
MW: molecular size standard.
doi:10.1371/journal.pone.0029306.g004
Figure 3. Characterization of the TetR/Pip OFF system in M. abscessus. M. abscessus S (A) and R (B) strains with pMC30A or pMC30B were
grown in Luria-Bertani broth and b-Galactosidase activity was measured in absence or in presence of 100, 200 or 300 ng/ml ATc at three time points
(24, 48 and 72 h). b-Galactosidase activity was expressed as the percentage of the residual activity in presence of ATc to the normal activity observed
in absence of ATc. Black bars 24 h; grey bars: 48 h; white bars: 72 h.
doi:10.1371/journal.pone.0029306.g003
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antibiotic, Nourtheothricin (http://www.webioage.com/) (Jun-
Rong Wei and Eric Rubin, personal communication) was shown
to be active against M. abscessus, and might represent only the
second efficient counterselective agent to be developed for use as
a genetic tool for M. abscessus. This further demonstrates the
difficulties encountered when working on M. abscessus, and
henceforth might impede the development of genetic tools
dedicated to this species.
Using the TetR/PipOFF system, we have demonstrated the
essential role of the fadD32 in M. abscessus. Although predictable -
fadD32 does plays an important role in the formation of the outer
membrane and in cell-wall permeability [39] making it essential
for M. tuberculosis and M. smegmatis [32] - this result nonetheless
proves the functionality of the adapted TetR/PipOFF system in
M. abscessus. This will permit further investigation of candidate
genes, such as those identified recently using a transcriptomic
approach to unravel the molecular mechanisms of the S/R switch
(Herrmann et al., unpublished, and [16]). Indeed, while we know
that the S/R switch is essential for M. abscessus to modulate the
innate immune response of the host [13,16], nothing is currently
known about the precise mechanisms involved. The development
of the TetR/PipOFF system may also allow the characterization of
the respective roles of candidate virulence genes recently identified
in the M. abscessus genome [17].
Materials and Methods
Bacterial strains, transformation condition and growth
conditions
Bacterial strains and plasmids are described in table 1 and on
figure 1. Bacteria were grown in Luria-Bertani (LB) broth at 37uC
with agitation. Ampicillin (100 mg/ml, Sigma, Saint-Louis, MO,
USA), kanamycin (50 mg/ml, Sigma, Saint-Louis, MO, USA),
zeocin (25 mg/ml for E. coli;5 0 mg/ml for mycobacteria,
Invitrogen, Paisley, UK), hygromycin (200 mg/ml, Roche Diag-
nostics, Mannheim, Germany), streptomycin (50 mg/ml, Sigma,
Saint-Louis, MO, USA) and X-gal (50 mg/ml, MP biomedicals,
Illkirch, France) were added when necessary. ATc (Sigma, Saint-
Louis, MO, USA) was added as required at concentrations starting
at 0 and up to 300 ng/ml. Preparation of electrocompetent cells,
electroporation and preparation of mycobacterial genomic DNA
were performed as previously described [40,41]. The plasmid
pJV53, which express recombinases [21], was electroporated in M.
abscessus. This plasmid is used to induce the crossing-over as
described previously [10]. After several sub-cultures in the absence
of a selective marker, the pJV53 plasmid can be lost by the strain,
as checked by kanamycin sensitivity.
Plasmids construction
Restriction endonucleases and modification enzymes (phospha-
tase and Klenow fragment) (New England Biolabs, Ipswich, UK)
were used according to the manufacturer’s instructions. PCRs
were performed using 1 U DyNazyme DNA polymerase (Finn-
zymes, Espoo, Finland) in 1X buffer, 200 mM concentration of
each deoxynucleoside triphosphate (MP biomedicals, Illkirch,
France), 0.8 mM concentration of each primer (Eurogentec,
Seraing, Belgium), and 10 ng of chromosomal DNA in a 50-ml
reaction volume. Cycling conditions were as follows: 1 cycle of
5 min at 94uC; 30 cycles of 20 s at 94uC, 20 s at 55uC, and 40 s/
kb at 72uC; with a final extension of 10 min at 72uC. PCR
products were separated in 1% agarose gels for 1 h at 10 V/cm of
gel. DNA fragments were purified from agarose gel by use of
a WizardH SV gel and PCR Clean-Up system (Promega, Madison,
WI, USA). E. coli DH5a strain (Invitrogen, Paisley, UK) was used
for cloning experiments.
Plasmid pMVlac was constructed starting with the restriction of
pMV306 plasmid by EcoRV followed by the ligation with the PCR
product Pptr-lacZ purified after amplification using primers MC77
and lacZ-3 using plasmid pFRA42A as target (Figure 1 and S2 and
Table 1 and 2). Plasmid pMC30A (Figure 1 and S2) was
constructed as a derivative of pMVlac after restriction by NcoI
followed by ligation of the restricted fragments PfurA102tetO-pip and
Psmyc-tetR both purified after SphI-EcoRI digestion of pFRA61
plasmid (Table 1). Plasmid pMC30B (Figure 1 and S2) represents
the opposite of pMC30A with PfurA102tetO-pip and Psmyc-tetR ligated
in opposite orientation in the NcoI site of pMV306 plasmid
(Table 1).
Zeocin, as a selective marker, was inserted by amplification with
primers ZeoF and ZeoR from the plasmid pLYG204-Zeo, then
restricted by SpeI and ligated into the plasmid pFRA50 previously
restricted by SpeI and purified, to create pMC14 (Table 1). 953 bp
of the 59 end of fadD32 (MAB_0179) was amplified using primers
fadF and fadR (Table 2) and then cloned into the NsiI site of
pMC14 which is located downstream of the Pptr promoter giving
plasmid pMC18 (Table 1 and Figure S1).
Construction of conditional mutants in M. abscessus
Plasmid pMC18 (Table 1), which contains the first 953 bases of
fadD32 (MAB_0179) under the control of the Pptr promoter, was
electroporated into M. abscessus strain bearing pJV53 (Table 1).
After a single cross-over event, pMC18 was integrated into the
chromosome giving the entire fad32 gene under the control of Pptr
promoter and a deleted part of fad32 gene under the control its
own promoter (strain fadD32
C, see Table 1). M. abscessus
recombinants were isolated afterwards on LB agar plates after
zeocin selection (50 mg/ml). Plasmid pMC18 integration by single
cross-over was checked by amplification using primers MC77 (on
Pptr promoter) and fadV (on 39end of fadD32) (Table 2). After
elimination of plasmid pJV53, plasmids pMC30A and pMC30B
(Table 1) were electroporated to obtain the final conditional
mutant fad32. After kanamycin (50 mg/ml) and X-gal (50 mg/ml)
selection on LB agar, strains S or R fadD32
C-pMC30A or –
pMC30B were obtained. Transformation with pMVlac (Table 1)
was performed (strains S or R fadD32
C-pMVlac) to control for
functionality of the plasmid without the two regulatory genes pip
and tetR.
Table 2. Primers used in this study.
Primer Name Sequence
fadF cgatgcatgcgttcgacaacccgttc
fadR cgatgcatattgatgatcgagtggatgt
fadV cggtgtattcgatgtcttg
lacZ-3 ttattattatttttgacaccagac
MC77 cgcatatgagatctccatcctgacgg
ZeoF ccgctagctcgagcac
ZeoR cgactagtgatccccgggaattc
MC82 agcgtgagctgctacaggac
MC83 tggatttccagcaccttctc
MC84 acatcgaatacaccgcacaa
MC85 ggattgtcgaaaaccacctg
doi:10.1371/journal.pone.0029306.t002
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b-galactosidase activity assay was performed as previously
described and enzymatic activity expressed in Miller units [42].
For M. abscessus R strains, OD600 nm was taken after sonication to
represent a homogenous suspension. Exponentially growing
culture cultivated at 37uC with agitation were diluted in new
media in the presence of 0, 100, 200, or 300 ng/ml of ATc and
incubated in similar conditions. At 24, 48 and 72 h, an aliquot was
taken to perform b-galactosidase activity assay. Each assay was
performed in triplicate. Results were expressed as the relative
percentage of Miller unit for the tested strain at a give time versus
Miller unit for the tested strain in the absence of ATc.
Assays on M. smegmatis mc
2155 derivative strains were
performed on culture prepared like described by Boldrin et al.
[30]. Briefly, cultures in liquid medium were grown 18 h with or
without ATc (50 ng/ml). After, culture without ATc was diluted in
new culture +/2 ATc (50 ng/ml), and culture with ATc was
diluted in same condition (with ATc). After 24 h, enzymatic
activity of b-galactosidase was measured. Each assay was
performed in triplicate.
Figure 5. Characterization of growth for conditional mutants in M. abscessus. (A) Bacteria were grown to exponential phase and 5 ml of 10-
fold serial dilutions were spotted onto LB agar medium supplemented or not with ATc 200 ng/ml. Plates were incubated at 37uC. Pictures were taken
after five days. Arrows indicate the difference of growth in presence or absence of ATc. (B) Diluted liquid culture of S fadD32
C-pMC30A and R fadD32
C-
pMC30A were separated in two cultures (one without ATc and one with 200 ng/ml ATc). After 48 h, cfu was numbered on LB agar plates. Results are
expressed in percentage of growth in comparison with the same strain culture without ATc.
doi:10.1371/journal.pone.0029306.g005
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10-fold serial dilutions were made from exponentially grown
cultures (37uC with agitation) in the absence of ATc, and 5 mlo f
each dilution was plated on LB agar in the presence or absence of
ATc (200 ng/ml). After five days, the presence of growth was
checkedforeachconditionandcomparison was performed between
plate with or without ATc. Each assay was performed in triplicate.
RNA extraction
Total RNA was extracted from 10 ml of bacteria in liquid culture
(with or without ATc at 200 ng/ml). Pellet of bacteria was mixed
with 1 ml of Trizol (Invitrogen, Paisley, UK) and placed in lysing
matrix B tubes (MP Biomedicals, Illkirch, France). Bacteria were
lysed by shaking in a Fastprep FP120 apparatus (MP Biomedicals,
Illkirch, France). Two hundred microliters of 1-bromo-3-chloro-
propane were added and tubes were centrifuged for 10 min at 10
000 g. The aqueous phase was recovered, and RNAs were
precipitated with 500 ml of isopropyl alcohol and washed with
ethanol 75%. RNAs were then resuspended in 50 ml of water,
treated with DNase I, and purified on RNeasy minicolumns
(Qiagen). The quantity and the quality of the RNAs were verified
spectrophotometrically (Nanodrop ND-1000) and on agarose gels.
qRT-PCR
Reverse transcriptase PCR (RT-PCR) was performed with
Superscript RT II (Invitrogen) using gene specific primer (MC83
and MC85, Table 2). The primer sequences were designed with
Primer3Plus online software [43]. Samples without RT were prepared
concurrently and analysed for the absence of contaminating genomic
DNA. Real-time quantitative PCR analysis was performed using
FastStart SYBR Green Master (Roche Diagnostics, Mannheim,
Germany). cDNAs obtained as described above were diluted ten-fold
in nuclease-free water before qPCR. The PCR program consisted of
35 amplifications/quantification cycles of 95uC for 15s and 60uCf o r1
min, with signal acquisition at the end of each cycle. MC82 and MC83
were used to amplify sigA and MC84 and MC85 to amplify fadD32
(Table 2). Equation 1 from Pfaffl [44] was used to analyse the statistical
significance of the data, using sigA as a reference gene standard. Each
assay was performed in duplicate and repeated at least twice.
Supporting Information
Figure S1 TetR/Pip OFF system mechanism and function of
plasmids used in this system.
(TIF)
Figure S2 Construction of pMC18, pMVlac, pMC30A and
pMC30B.
(TIF)
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